“…Major functions of ARF6 include cytoskeletal organization and actin remodeling, roles in endocytosis and vesicular trafficking, cell adhesion, and completion of mitotic cytokinesis in different cell types (D'Souza-Schorey and Chavrier, 2006;Donaldson, 2002;Hongu and Kanaho, 2014;Humphreys et al, 2013;Klein et al, 2006;Luton, 2005;Schafer et al, 2000;Schweitzer and D'Souza-Schorey, 2005). Accordingly, it promotes processes based on actin assembly and cytoskeletal organization, including migration, branching and outgrowth in neuronal cells, filopodia extension, platelet-mediated clot formation and thrombosis, or tumor angiogenesis and metastasis (Charles et al, 2016;Choi et al, 2005;Gauthier-Campbell et al, 2004;Hiroi et al, 2006;Hongu et al, 2016;Miura et al, 2016;Torii et al, 2010;Urban et al, 2016). With NAV2729, a small molecule inhibitor with presumed specificity for ARF6 is available (Yamauchi et al, 2017;Yoo et al, 2016).…”